1502874-00-1

Basic information

• Product Name: C₁₉H₁₇NO₅S
• Synonyms: C₁₉H₁₇NO₅S
• CAS NO: 1502874-00-1
• Molecular Weight: 371.414
• Mol File: 1502874-00-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: C₁₉H₁₇NO₅S(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₉H₁₇NO₅S(1502874-00-1)
• EPA Substance Registry System: C₁₉H₁₇NO₅S(1502874-00-1)

Safety Data

• Hazardous Substances Data: 1502874-00-1(Hazardous Substances Data)

Upstream product

• 112111-43-0 Modafinil 
• 68524-29-8 benzhydrylsulfanyl acetyl chloride 
• 68524-30-1 2-(diphenylmethylthio)acetamide 
• 63547-22-8 (benzhydrylthio)acetic acid 
• 776-74-9 Bromodiphenylmethane 
• 1502873-99-5 C₂₀H₁₉NO₅S 

Relevant articles and documents

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DEGENERATIVE DISORDERS AND NEUROLOGICAL DISEASES

The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for the treatment of neurological degenerative disorders and neurological diseases may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of narcolepsy, shift work sleep disorder, and as an adjunct treatment for obstructive sleep apnea/hypopnea, hypersomnias, like idiopathic hypersomnia, Psychiatric/neurodegenerative disorders, ADHD, Psychiatric/neurodegenerative disorders, Depersonalization disorder, Cognitive enhancement, Fatigue, Post-chemotherapy cognitive impairment and weight loss.